Diabetes complications

Impact of glycemic optimization on myocardial steatosis and cardiac remodeling in patients with newly diagnosed type 2 diabetes: a longitudinal study

Cardiovasc DiabetolPublished Uncontrolled exploratory longitudinal study

Authors' conclusion

In patients with newly diagnosed T2D, 12 months of glycemic optimization was associated with changes in cardiac remodeling parameters despite no detectable changes in myocardial steatosis. The observed cardiac changes were more closely associated with concurrent reductions in adiposity markers than with changes in HbA1c, emphasizing weight management as a key target for early prevention of diabetic cardiomyopathy.

Study context

Population
Adults with newly diagnosed T2D; mean age 54.8 ± 9 years, 72.3% male
Participants
20 adults
Exposure
12 months of glycaemic optimization vs baseline
Outcome
Longitudinal changes in myocardial triglyceride content (MTGC) and cardiac remodeling (CMR, ¹H-MRS)
Follow-up
12 months

Main finding

As reported in the abstract

MTGC
  • No significant changes in myocardial triglyceride content (MTGC) at follow-up
  • 12 months vs Baseline: P = 0.23

Observational data: associations, not effects.

Further findings

Left ventricle (LV) ejection fraction · baseline to 12 months

LV ejection fraction increased
P = 0.01

LV end-systolic volume · baseline to 12 months

LV end-systolic volume decreased
P = 0.007

Right ventricular (RV) end-systolic volume · baseline to 12 months

RV end-systolic volume decreased
P = 0.02

RV end-diastolic volume · baseline to 12 months

RV end-diastolic volume decreased
P = 0.03

Indexed LV mass · baseline to 12 months

Indexed LV mass increased
P = 0.006

HbA1c, body mass index (BMI) and waist circumference (WC) · 12 months

Significant reductions in HbA1c, BMI and WC

Associations of HbA1c improvement with MTGC or CMR parameters

No associations between HbA1c improvement and MTGC or CMR parameters

Associations of adiposity reductions with cardiac parameters

Reductions in BMI and WC associated with greater left atrial strain (ρ)
- 0.78 and - 0.77; p < 0.001
Reductions in WC associated with greater LV end-diastolic volume (ρ)
−0.59; p = 0.024

Original publication

Impact of glycemic optimization on myocardial steatosis and cardiac remodeling in patients with newly diagnosed type 2 diabetes: a longitudinal study. Cardiovasc Diabetol. Published 6 March 2026. doi:10.1186/s12933-026-03105-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.